Safety and efficacy profile ofbioresorbable-polylactide-polymer-biolimus-A9-eluting stents versusdurable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome-Reference-Cited by-同舟云学术

Safety and efficacy profile ofbioresorbable-polylactide-polymer-biolimus-A9-eluting stents versusdurable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome

Published:2016-07-05 Issue:6 Volume:88 Page:E173-E182
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Jaguszewski Milosz¹,Dörig Manuela¹,Frangieh Antonio H.¹,Ghadri Jelena-Rima¹,Cammann Victoria Lucia¹,Diekmann Johanna¹,Napp L. Christian²,D'Ascenzo Fabrizio¹,Imori Yoichi¹,Obeid Slayman¹,Maier Willibald¹,Lüscher Thomas F.¹,Templin Christian¹

Affiliation:

1. Cardiology, Cardiovascular Center, University Hospital Zurich; Zurich Switzerland

2. Department of Cardiology and Angiology; Hannover Medical School; Hannover Germany

Funder

Swiss National Science Foundation “Special Program University Medicine” (SPUM)

strategic alliance with Pfizer, Inc., New York, USA

Research grants from Eli Lilly, Inc., Indianapolis, In., USA, Astra Zeneca, Zug, Switzerland, Medtronic, Tolochenaz, Switzerland and Biosensors, Lausanne, Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference34 articles.

1. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis;Stettler;Lancet,2007

2. Stent thrombosis: No longer an issue with newer-generation drug-eluting stents?;Stefanini;Circ Cardiovasc Interv,2012

3. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-Cypher registry;Urban;Circulation,2006

4. Drug-eluting coronary-artery stents;Stefanini;N Engl J Med,2013

5. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial;Sabate;Lancet,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease;Journal of Interventional Cardiology;2023-12-13

2. Critical evaluation of stents in coronary angioplasty: a systematic review;BioMedical Engineering OnLine;2021-05-08

3. Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome;International Heart Journal;2018

4. A comparison of the main outcomes from BP-BES and DP-DES at five years of follow-up: A systematic review and meta-analysis;Scientific Reports;2017-11-03

5. A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study;Catheterization and Cardiovascular Interventions;2016-10-24